A review of Perindopril in the reduction of cardiovascular events

Item

http://www.wikidata.org/entity/Q36012986

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

A review of Perindopril in the reduction of cardiovascular events

@ast

A review of Perindopril in the reduction of cardiovascular events

@en

type

Item

label

A review of Perindopril in the reduction of cardiovascular events

@ast

A review of Perindopril in the reduction of cardiovascular events

@en

prefLabel

A review of Perindopril in the reduction of cardiovascular events

@ast

A review of Perindopril in the reduction of cardiovascular events

@en

P1476

A review of Perindopril in the reduction of cardiovascular events

@en

P2093

Duncan J Campbell

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

ABC of hypertension: The pathophysiology of hypertension

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

P304

117-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/VHRM.2006.2.2.117

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6487714

http://www.w3.org/2001/XMLSchema#string

P698

17319455

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

cardiovascular disease

arterial hypertension

P932

1993997

http://www.w3.org/2001/XMLSchema#string